Gregor Hutter

14PUBLICATIONS
103CO-AUTHORS
Molecular targetsHaematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 22, 2026
Recent Locoregional CAR T-Cell Trials for the Treatment of Recurrent Glioblastoma: Implications for Neuro-Oncology Practice.

|Nov 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections.

Natalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic

|Jun 18, 2025
Adoptive cell therapy with macrophage-drug conjugates facilitates cytotoxic drug transfer and immune activation in glioblastoma models.

Miaomiao Sun, Maciej Bialasek, Maud Mayoux

|May 22, 2025
FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma.

Michal Beffinger, Linda Schellhammer, Betül Taskoparan

|Nov 09, 2024
Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.

Tomás A Martins, Deniz Kaymak, Nazanin Tatari

|Jul 19, 2023
Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.

Philip Schmassmann, Julien Roux, Alicia Buck

Pageof 3

Frequent Collaborators

4 joint publications

Tomas A Martins

4 joint publications

Manina Maja Etter

3 joint publications

Siddhartha S Mitra

3 joint publications

Nazanin Tatari